"Do You have a case against Tyco?"
A lawsuit has been filed in the United States District Court, Middle District of Tennessee, Nashville Division on behalf of clients against Tyco International, Ltd. (NYSE: TYC), because of serious injuries caused by dye injection used in magnetic resonance imaging (MRI) scans.
In 2004, the plaintiff, a kidney failure patient, underwent an enhanced MRI, which included injecting the drug OptiMARK, a gadolinium-based dye, used as a contrast agent. One week after the MRI, he began showing signs of Nephrogenic Systemic Fibrosis (NSF). His symptoms included thickened skin around both elbows and both knees, pain in both legs, knees, and elbows along with trouble walking.
The FDA has recalled gadolinium dyes stating: Patients with moderate to end-stage kidney disease who receive an MRI with a gadolinium-based contrast agent may get NSF, which is debilitating and may cause death.
The suit charges the defendants as knowing that the dye could cause NSF in kidney patients, but continued to distribute it. They also failed to warn physicians of the risks of kidney patients potentially developing NSF.
It was very risky for him to receive the dye injection before the MRI. The attorney will try to prove that the defendants have known for years that kidney disease patients who receive the injection of gadolinium-based dye were at very high risks for developing NSF, which is a horrible medical condition. Unfortunately, the defendants chose to conceal the risk of the procedure.